These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10209506)

  • 1. HLA-DMB expression by thyrocytes: indication of the antigen-processing and possible presenting capability of thyroid cells.
    Wu Z; Biro PA; Mirakian R; Hammond L; Curcio F; Ambesi-Impiombato FS; Bottazzo GF
    Clin Exp Immunol; 1999 Apr; 116(1):62-9. PubMed ID: 10209506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
    Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS
    J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease.
    Iwatani Y; Gerstein HC; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells.
    Hershberg RM; Cho DH; Youakim A; Bradley MB; Lee JS; Framson PE; Nepom GT
    J Clin Invest; 1998 Aug; 102(4):792-803. PubMed ID: 9710448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients.
    Pachot A; Monneret G; Brion A; Venet F; Bohé J; Bienvenu J; Mougin B; Lepape A
    Crit Care Med; 2005 Jan; 33(1):31-8; discussion 236-7. PubMed ID: 15644645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules.
    Catálfamo M; Serradell L; Roura-Mir C; Kolkowski E; Sospedra M; Vives-Pi M; Vargas-Nieto F; Pujol-Borrell R; Jaraquemada D
    Int Immunol; 1999 Feb; 11(2):269-77. PubMed ID: 10069425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separate induction of MHC and thyroid microsomal antigen (McAg) expression on thyroid cell monolayers: enhancement of lectin-induced McAg expression by interferon-gamma.
    Iwatani Y; Iitaka M; Gerstein HC; Row VV; Volpé R
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1302-8. PubMed ID: 3106398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperexpression of transporter in antigen processing-1 (TAP-1) in thyroid glands affected by autoimmunity: a contributing factor to the breach of tolerance to thyroid antigens?
    Sospedra M; Tolosa E; Armengol P; Ashhab Y; Urlinger S; Lucas-Martin A; Foz-Sala M; Jaraquemada D; Pujol-Borrell R
    Clin Exp Immunol; 1997 Jul; 109(1):98-106. PubMed ID: 9218831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
    Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
    J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of staphylococcal enterotoxin B on thyrocyte HLA molecule expression.
    Fierabracci A; Hammond L; Lowdell M; Chiovato L; Goode AW; Bottazzo GF; Mirakian R
    J Autoimmun; 1999 Jun; 12(4):305-14. PubMed ID: 10330302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
    J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo HLA class II and enhanced HLA class I molecule expression in SV40 transfected human thyroid epithelial cells.
    Belfiore A; Mauerhoff T; Pujol-Borrell R; Badenhoop K; Buscema M; Mirakian R; Bottazzo GF
    J Autoimmun; 1991 Jun; 4(3):397-414. PubMed ID: 1654916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression.
    Aguayo J; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma.
    Siegrist CA; Martinez-Soria E; Kern I; Mach B
    J Exp Med; 1995 Dec; 182(6):1793-9. PubMed ID: 7500024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
    Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
    FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.